(The news
featured below is a selection from the news covered in the Federal Securities
Report Letter, which is distributed to subscribers of the Federal
Securities Law Reports.)
Key Senators Urge SEC to Stand Firm on Insider Loans
In a letter to SEC Chairman Harvey L. Pitt, Senators Carl Levin and Susan
Collins urged the Commission to resist any weakening of the ban on loans to
corporate executives embodied in the Sarbanes-Oxley Act. The legislators
mentioned recent media reports indicating that some companies are lobbying the
SEC to weaken the loan prohibition. Sen. Levin is chairman of the Permanent
Subcommittee on Investigations, and Sen. Collins is the subcommittee’s ranking
member. They emphasized that the SEC should resist efforts to weaken what they
called "a significant post-Enron reform" and enforce this
"bright-line" measure to end corporate loan abuses by top executives.
In Section 402, the Sarbanes-Oxley Act bans loans by a public company to any
of its directors or executive officers. The statute provides limited exceptions
to the loan prohibition, which is designed to sharply limit the types of hidden
compensation that can be offered to corporate executives. In the letter, the
senators point out that the statutory prohibition makes it clear that public
companies are not supposed to be using corporate funds to provide personal
financing to company directors or officers for any reason. Media reports
indicate, however, that some companies may be pressing the SEC to narrow the
scope of the prohibition or otherwise weaken it through regulation, guidance, or
other means.
These media reports suggest that opponents want exemptions for company loans
used by executives to purchase company stock, exercise stock options, obtain
insurance, relocate for work or pay taxes. The act's legislative history
provides no basis for creating these exemptions or otherwise weakening the
provision, emphasized the senators. They emphasized that the statutory
prohibition makes it clear that public companies are not supposed to be using
company funds to provide personal financing to directors or officers for any
reason.
|